Home » Topics » Regulatory

Regulatory
RSS

FDA approves Heron Therapeutics' Sustol for chemotherapy-induced nausea and vomiting

Aug. 11, 2016

FDA approves Merck & Co.'s Keytruda for patients with recurrent or metastatic HNSCC

Aug. 8, 2016

AstraZeneca receives European approval for Qtern

July 20, 2016

FDA approves Kovanaze nasal spray for dental anesthesia

July 13, 2016

FDA approves Xiidra to treat signs and symptoms of dry eye disease

July 12, 2016

Revestive approved in Europe for pediatric patients with short bowel syndrome

July 7, 2016

FDA approves InSys Therapeutic's Syndros

July 6, 2016

European Commission approves Ongentys in Parkinson's disease

July 5, 2016

Japan first to approve Lumicef worldwide

July 4, 2016

FDA approves Epclusa as pan-genotypic single-tablet regimen for chronic HCV infection

June 29, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...